Sensei Biotherapeutics, Inc.
General ticker "SNSE" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $18.3M (TTM average)
Sensei Biotherapeutics, Inc. follows the US Stock Market performance with the rate: 26.7%.
Estimated limits based on current volatility of 7.2%: low 32.04$, high 36.98$
Factors to consider:
- Total employees count: 28 as of 2023
- Top business risk factors: Inability to raise capital, Inability to achieve profitability, Clinical trial failure, Regulatory and compliance, Labor/talent shortage/retention
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.72$, 15.80$]
- 2026-12-31 to 2027-12-31 estimated range: [3.94$, 11.59$]
Financial Metrics affecting the SNSE estimates:
- Negative: with PPE of -0.6 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 170.59 > -0.60
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.28 <= 0.74
Short-term SNSE quotes
Long-term SNSE plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $37.06MM | $31.66MM | $22.29MM |
| Operating Income | $-37.06MM | $-31.66MM | $-22.29MM |
| Non-Operating Income | $2.96MM | $1.51MM | $1.21MM |
| Interest Expense | $0.14MM | $0.09MM | $0.03MM |
| R&D Expense | $18.30MM | $18.63MM | $10.96MM |
| Income(Loss) | $-34.10MM | $-30.16MM | $-21.08MM |
| Net Income(Loss)* | $-34.10MM | $-30.16MM | $-21.09MM |
| Stockholders Equity | $64.89MM | $38.39MM | $18.59MM |
| Assets | $74.37MM | $45.36MM | $22.90MM |
| Operating Cash Flow | $-32.02MM | $-24.67MM | $-20.45MM |
| Capital expenditure | $0.18MM | $0.15MM | $0.02MM |
| Investing Cash Flow | $38.41MM | $22.44MM | $19.77MM |
| Financing Cash Flow | $-11.17MM | $-0.79MM | $-0.65MM |
| Earnings Per Share** | $-1.22 | $-1.20 | $-16.72 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.